Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B Dysfunction — Claudia Angela Maria Fulgenzi (2024) | RDL Network
Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B Dysfunction
Article 2024 en
Authors
CF
Claudia Angela Maria Fulgenzi
BS
Bernhard Scheiner
AD
Antonio D’Alessio
Abstract
1 min read
The results of this case series provide comparative evidence of improved survival in association with ICI treatment compared with BSC in patients with uHCC with CP-B liver dysfunction.
Discussion(0)
No comments yet. Be the first to comment.